Raf joined Korys in January 2017. Raf started his career at Eurogentec, a life science tools provider and CDMO based in Belgium. Before Korys, he worked as Business Development Manager for Apitope, a clinical stage biotech company based in the UK and Belgium, developing antigen-specific immunotherapies for autoimmune disorders. There he managed both dilutive and non-dilutive financing strategies and focused on the company’s licensing activities.
Raf holds a Master of Science in Biochemistry and Biotechnology from the University of Leuven (KUL) and an MBA from Vlerick Business School (Brussels). He is board member of Ontoforce, ReMYND, MRM Technologies and MRM Health.